BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Vrije Universiteit Amsterdam//NONSGML v1.0//EN
NAME:PhD defence J.F.M. Smits
METHOD:PUBLISH
BEGIN:VEVENT
DTSTART:20260519T094500
DTEND:20260519T111500
DTSTAMP:20260519T094500
UID:2026/phd-defence-j-f-m-smits@8F96275E-9F55-4B3F-A143-836282E12573
CREATED:20260603T090852
LOCATION:(1st floor) Auditorium, Main building De Boelelaan 1105 1081 HV Amsterdam
SUMMARY:PhD defence J.F.M. Smits
X-ALT-DESC;FMTTYPE=text/html: <html> <body> <p>To GVB or not to GVB</p
 > <p><strong>New insights into resilient brain cells offer hope for A
 lzheimer's research</strong><br><br>Neurodegenerative diseases, such 
 as Alzheimer's, pose an increasing challenge to society due to the ag
 ing population. In these conditions, nerve cells in the brain gradual
 ly die off, leading to memory loss, cognitive decline, and ultimately
  a loss of independence. Because neurons cannot renew themselves, dam
 age is often irreversible. However, research by neuroscientist Jasper
  Smits shows that not all brain cells are equally vulnerable: some po
 ssess surprising protective mechanisms.</p><p>Smits investigated how 
 neurons cope with harmful accumulations of the protein tau, a hallmar
 k of Alzheimer's. This protein can misfold and clump together, disrup
 ting essential processes within the cell. He investigated why some ne
 urons survive this stress while others die.</p><p><strong>Granulovacu
 olar degeneration vesicles (GVBs)</strong><br>Smits' study shows that
  a specific cellular process plays a key role in this. Under the infl
 uence of tau clumping, neurons form so-called granulovacuolar degener
 ation vesicles (GVBs). These are specialized structures that appear t
 o be part of the cell's cleanup system. Their formation proves to dep
 end on both the protein CK1δ and autophagy, the mechanism by which c
 ells break down and recycle damaged components.</p><p>The difference 
 between neurons with and without these GVBs is striking. Cells withou
 t GVBs show a sharp decline in protein production and eventually die.
  Neurons that do form GVBs, on the other hand, continue to produce pr
 oteins and survive longer. This is associated with increased producti
 on of ribosomes, the structures responsible for protein synthesis. Th
 is protective response occurs in tau and other diseases, but whether 
 they play the same protective role there has yet to be demonstrated.<
 /p><p><strong>Active neurons</strong><br>The results change the perce
 ption of brain cells as passive victims of disease. Instead, they dem
 onstrate that neurons actively attempt to limit damage and protect th
 emselves against protein stress. This insight has important societal 
 implications. By better understanding how these natural defense mecha
 nisms work, researchers can develop new treatments that not only targ
 et harmful protein clumps but also strengthen the resilience of brain
  cells. This opens up the possibility for combined therapies that com
 bat both the cause and the consequences of neurodegeneration.<br><br>
 In the longer term, this can contribute to slowing disease processes 
 such as Alzheimer's, preserving cognitive functions longer, and impro
 ving the quality of life for patients. Consequently, this research of
 fers not only scientific progress but also a future perspective for a
  growing group of people facing these devastating conditions.</p><p>M
 ore information on the <a href="https://hdl.handle.net/1871.1/cb3cc91
 9-95f6-4584-9957-958950a4c146" data-new-window="true" target="_blank"
  rel="noopener noreferrer">thesis</a></p> </body> </html>
DESCRIPTION: <strong>New insights into resilient brain cells offer hop
 e for Alzheimer's research</strong><br><br>Neurodegenerative diseases
 , such as Alzheimer's, pose an increasing challenge to society due to
  the aging population. In these conditions, nerve cells in the brain 
 gradually die off, leading to memory loss, cognitive decline, and ult
 imately a loss of independence. Because neurons cannot renew themselv
 es, damage is often irreversible. However, research by neuroscientist
  Jasper Smits shows that not all brain cells are equally vulnerable: 
 some possess surprising protective mechanisms. Smits investigated how
  neurons cope with harmful accumulations of the protein tau, a hallma
 rk of Alzheimer's. This protein can misfold and clump together, disru
 pting essential processes within the cell. He investigated why some n
 eurons survive this stress while others die. <strong>Granulovacuolar 
 degeneration vesicles (GVBs)</strong><br>Smits' study shows that a sp
 ecific cellular process plays a key role in this. Under the influence
  of tau clumping, neurons form so-called granulovacuolar degeneration
  vesicles (GVBs). These are specialized structures that appear to be 
 part of the cell's cleanup system. Their formation proves to depend o
 n both the protein CK1δ and autophagy, the mechanism by which cells 
 break down and recycle damaged components. The difference between neu
 rons with and without these GVBs is striking. Cells without GVBs show
  a sharp decline in protein production and eventually die. Neurons th
 at do form GVBs, on the other hand, continue to produce proteins and 
 survive longer. This is associated with increased production of ribos
 omes, the structures responsible for protein synthesis. This protecti
 ve response occurs in tau and other diseases, but whether they play t
 he same protective role there has yet to be demonstrated. <strong>Act
 ive neurons</strong><br>The results change the perception of brain ce
 lls as passive victims of disease. Instead, they demonstrate that neu
 rons actively attempt to limit damage and protect themselves against 
 protein stress. This insight has important societal implications. By 
 better understanding how these natural defense mechanisms work, resea
 rchers can develop new treatments that not only target harmful protei
 n clumps but also strengthen the resilience of brain cells. This open
 s up the possibility for combined therapies that combat both the caus
 e and the consequences of neurodegeneration.<br><br>In the longer ter
 m, this can contribute to slowing disease processes such as Alzheimer
 's, preserving cognitive functions longer, and improving the quality 
 of life for patients. Consequently, this research offers not only sci
 entific progress but also a future perspective for a growing group of
  people facing these devastating conditions. More information on the 
 <a href="https://hdl.handle.net/1871.1/cb3cc919-95f6-4584-9957-958950
 a4c146" data-new-window="true" target="_blank" rel="noopener noreferr
 er">thesis</a> To GVB or not to GVB
END:VEVENT
END:VCALENDAR
